UniProt ID | CL045_HUMAN | |
---|---|---|
UniProt AC | Q8N5I9 | |
Protein Name | Uncharacterized protein C12orf45 | |
Gene Name | C12orf45 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 185 | |
Subcellular Localization | ||
Protein Description | ||
Protein Sequence | MEVHGKPKASPSCSSPTRDSSGVPVSKELLTAGSDGRGGIWDRLLINSQPKSRKTSTLQTVRIERSPLLDQVQTFLPQMARANEKLRKEMAAAPPGRFNIENIDGPHSKVIQMDVALFEMNQSDSKEVDSSEESSQDSSENSSESEDEDDSIPSEVTIDNIKLPNSEGGKGKIEVLDSPASKKKK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Acetylation | --MEVHGKPKASPSC --CCCCCCCCCCCCC | 28.59 | 23749302 | |
10 | Phosphorylation | VHGKPKASPSCSSPT CCCCCCCCCCCCCCC | 24.38 | 23927012 | |
12 | Phosphorylation | GKPKASPSCSSPTRD CCCCCCCCCCCCCCC | 24.92 | 23927012 | |
14 | Phosphorylation | PKASPSCSSPTRDSS CCCCCCCCCCCCCCC | 43.63 | 23401153 | |
15 | Phosphorylation | KASPSCSSPTRDSSG CCCCCCCCCCCCCCC | 34.32 | 23401153 | |
17 | Phosphorylation | SPSCSSPTRDSSGVP CCCCCCCCCCCCCCC | 49.40 | 29255136 | |
20 | Phosphorylation | CSSPTRDSSGVPVSK CCCCCCCCCCCCCCH | 26.21 | 23927012 | |
21 | Phosphorylation | SSPTRDSSGVPVSKE CCCCCCCCCCCCCHH | 48.36 | 23927012 | |
26 | Phosphorylation | DSSGVPVSKELLTAG CCCCCCCCHHHHCCC | 17.84 | 23927012 | |
27 | Ubiquitination | SSGVPVSKELLTAGS CCCCCCCHHHHCCCC | 53.25 | 29967540 | |
31 | Phosphorylation | PVSKELLTAGSDGRG CCCHHHHCCCCCCCC | 41.41 | 25627689 | |
34 | Phosphorylation | KELLTAGSDGRGGIW HHHHCCCCCCCCCCH | 34.13 | 21815630 | |
37 | Methylation | LTAGSDGRGGIWDRL HCCCCCCCCCCHHHH | 45.19 | - | |
48 | Phosphorylation | WDRLLINSQPKSRKT HHHHHCCCCCCCCCC | 40.65 | 25159151 | |
51 | Ubiquitination | LLINSQPKSRKTSTL HHCCCCCCCCCCCCC | 56.08 | 24816145 | |
54 | Ubiquitination | NSQPKSRKTSTLQTV CCCCCCCCCCCCEEE | 54.65 | 24816145 | |
55 | Phosphorylation | SQPKSRKTSTLQTVR CCCCCCCCCCCEEEE | 26.32 | 23312004 | |
56 | Phosphorylation | QPKSRKTSTLQTVRI CCCCCCCCCCEEEEE | 30.10 | 28857561 | |
57 | Phosphorylation | PKSRKTSTLQTVRIE CCCCCCCCCEEEEEE | 28.28 | 23312004 | |
60 | Phosphorylation | RKTSTLQTVRIERSP CCCCCCEEEEEECCH | 18.18 | 23312004 | |
66 | Phosphorylation | QTVRIERSPLLDQVQ EEEEEECCHHHHHHH | 13.70 | 25159151 | |
79 | Sulfoxidation | VQTFLPQMARANEKL HHHHHHHHHHHHHHH | 2.29 | 21406390 | |
88 | Ubiquitination | RANEKLRKEMAAAPP HHHHHHHHHHHCCCC | 63.38 | 29967540 | |
123 | Phosphorylation | ALFEMNQSDSKEVDS EEEECCCCCCCCCCC | 38.56 | 28348404 | |
125 | Phosphorylation | FEMNQSDSKEVDSSE EECCCCCCCCCCCCH | 35.64 | 28102081 | |
134 | Phosphorylation | EVDSSEESSQDSSEN CCCCCHHHCCCCCCC | 29.28 | - | |
135 | Phosphorylation | VDSSEESSQDSSENS CCCCHHHCCCCCCCC | 41.09 | - | |
162 | Ubiquitination | EVTIDNIKLPNSEGG EEEEEEEECCCCCCC | 65.23 | - | |
172 | Ubiquitination | NSEGGKGKIEVLDSP CCCCCCCCEEECCCC | 38.90 | - | |
178 | Phosphorylation | GKIEVLDSPASKKKK CCEEECCCCHHHCCC | 20.43 | 19664994 | |
181 | Phosphorylation | EVLDSPASKKKK--- EECCCCHHHCCC--- | 48.68 | 30266825 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CL045_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CL045_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CL045_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TBC23_HUMAN | TBC1D23 | physical | 21988832 | |
PR38A_HUMAN | PRPF38A | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-178, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-178, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-34; SER-48; SER-66 ANDSER-178, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66, AND MASSSPECTROMETRY. |